Vepafestinib
Vepafestinib is a small molecule inhibitor targeting the RET kinase, exhibiting promising antineoplastic properties. It is utilized in oncology research to study RET-driven cancers, with applications in both in vitro biochemical assays and in vivo tumor model studies.
Product Specifications
CAS Number
2129515-96-2
Product Name Alternative
CRET, Vepafestinib, RET
Field of Research
Cell Biology, Signal Transduction
Purity
98.54% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.11 mM) ; DMSO:45 mg/mL (94.83 mM)
Smiles
COCc1ccc (NC (=O) c2c (C#CCN3CCOCC3) n (c3ncnc (N) c23) C2 (C) CC2) cc1
Molecular Formula
C26H30N6O3
Molecular Weight
474.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV673183 1.0 µg DNA
CRHR2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 